External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology Retina World Congress 2024
Roche and Genentech at

Retina World Congress 2024

May 09 - May 12
Florida, USA
retinaworldcongress.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
11:00 AM
Duration 1hr United States
Key Clinical and Anatomical Outcomes With Faricimab▼ in Patients With nAMD: Results From the TENAYA/LUCERNE Trials
Souied E, Haug S, Amador M, Kotecha A, Margaron P, Stoilov I, Tang Y
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr United States
ELEVATUM Study Design and Rationale: A Phase 4 Trial of Faricimab▼ (VABYSMO) in Underrepresented Patients With DME
Cunningham M, Brown J, Scott A, Amador M, Chang J, Stoilov I, Meldorf M, Coney J, Gonzalez L
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr United States
Efficacy and Safety of Faricimab▼ in ALTIMETER: A Trial Exploring Biomarkers of Ang-2 Inhibition in Patients With DME
Choudhry N, Amador M, Dieckmann A, Gibson K, Glittenberg C, Kotak A, Mar F, Souverain A, Titz B, Vujosevic S, Fawzi A
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr United States
Assessment of the Clinical Effects of Anti-Ang-2 With Faricimab▼ Based on Key Outcomes From the YOSEMITE/RHINE Trials in Patients With DME
Udaondu P, Kim J, Manoharan N, Amador M, Willis J,Stoilov I, Mar F, Gibson K, Souverain A
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr United States
Real-World Effectiveness and Durability of Faricimab▼ in Patients with Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: The FARWIDE and FARETINA studies
Borkar D, Tabano D, Ko S, Leng T, Myers R, Singh R, Talks J, Peto T, Dayal P, Downey A, James N, Chi G
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr United States
IL-6 Inhibition With Vamikibart in Patients With Uveitic Macular Edema: Phase 3 MEERKAT and SANDCAT Trials
Uchiyama E
Ophthalmology | Uveitis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Florida, USA
Port Delivery System with Ranibizumab (PDS) Stabilizes Retinal Nonperfusion in Patients with Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR): Results from Pagoda and Pavilion Phase 3 Trials
Emanuelli A, Campochiaro P, Wirthlin R, Gill M, Howard D, Menzes A, Malhotra V, Singh N, Latkany P
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Florida, USA
Long-term Efficacy and Safety of the Port Delivery System With Ranibizumab in Patients With nAMD: Results From the Portal 5-year Subgroup Analysis
Eichenbaum D, Gune S, Singh N, Cavichini M
Ophthalmology | Diabetic Retinopathy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:38 PM
Duration 5mins United States
Real-World Clinical and Anatomical Outcomes in Patients with Neovascular Age-Related Macular Degeneration Treated with Faricimab▼: the FARETINA-AMD Study
Ali F
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:40 PM
Duration 5mins United States
Efficacy, Safety, and Durability of Faricimab▼ in Macular Edema Due to Retinal Vein Occlusion: 72-Week Results From the Phase 3 BALATON and COMINO Trials
Danzig C
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.